All research
Retatrutide 2026-09-11 PubMed

Beyond Fat Loss: Addressing the Sarcopenia Challenge of Incretin-Based Therapies.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


incretin glp-1ra gip-agonist obesity type-2-diabetes sarcopenia
Source: pubmed:42722378 · Ingested Sep 11, 2026